NICE· @NICEComms · X·· 20 天前精选AI 评分62
AI 导读
NICE 推荐一款新的多发性骨髓瘤治疗方案，适用于新诊断患者，超过 1,760 人可能从中受益。NICE 表示，证据显示该方案相比标准治疗可帮助患者延长生存时间，并更长时间控制疾病。相关指南文件已在 NICE 官网的指南制定页面公布。
推荐理由
NICE 推荐多发性骨髓瘤新治疗方案，读者可了解该推荐覆盖的患者规模及其相对标准治疗的证据依据。
正文
More than 1,760 people with newly diagnosed multiple myeloma could benefit from a new NICE-recommended treatment option.
Evidence shows it can help people live longer and keep the disease under control for longer than standard treatment:
https://www.nice.org.uk/guidance/indevelopment/gid-ta11254/documents?utm_medium=organic&utm_source=x&utm_campaign=daratumumab_100926&utm_content=graphic
来源：NICE · x.com